Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets
Type 2 diabetes is a common metabolic disorder related to insulin resistance, or deficiency of insulin secretion, caused by decreased insulin sensitivity and destruction of islet structure and function. As the second human genome, the microbiota has been observed to have a growing relationship with...
Main Authors: | Hui Wang, Yuan Lu, Yan Yan, Shanshan Tian, Dongjie Zheng, Dongjing Leng, Cao Wang, Jingfeng Jiao, Zhiguo Wang, Yunlong Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2019.00455/full |
Similar Items
-
Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges
by: Arndt Steube, et al.
Published: (2023-03-01) -
Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients
by: Fengqiong Liu, et al.
Published: (2021-02-01) -
Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue?
by: Mark Stuntz, et al.
Published: (2015-10-01) -
Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition
by: Claudia Burrello, et al.
Published: (2019-05-01) -
Fecal microbiota transplantation via colonoscopy in a dog with Clostridioides (Clostridium) difficile infection
by: Amanda Nadia Diniz, et al.
Published: (2021-02-01)